BiotechTube
Home/Pipeline/PROGRAM-3

PROGRAM-3

Undisclosed

DiscoveryActive

Key Facts

Indication
Undisclosed
Phase
Discovery
Status
Active
Company
Optieum Biotechnologies

About Optieum Biotechnologies

A Japanese biotech developing optimized CAR-T therapies for solid tumors and autoimmune disorders using its proprietary Eumbody discovery platform.

View full company profile

Therapeutic Areas

OncologyImmunology

Other Undisclosed Drugs

DrugCompanyPhase
Preclinical ISAC 1Bolt BiotherapeuticsPreclinical
Preclinical ISAC 2Bolt BiotherapeuticsPreclinical
ART12.11Artelo BiosciencesPreclinical
Novel VaccinesMSDDevelopment
SLS-009Seelos TherapeuticsDiscovery
Technosphere Platform (New Formulations)MannKindDiscovery/Preclinical
Measovir®-based Prophylactic Vaccine (with Unither)OncovitaResearch/Pre-clinical
Internal sdAb Discovery ProgramNanoTag BiotechnologiesDiscovery
NB-701Nerai BiosciencesDiscovery
Undisclosed Therapeutic Program(s)Bright CellClinical Trial (Phase unspecified)
Biosimilars PipelineIntelligent TherapeuticsPre-clinical/Development
Proprietary Therapeutic PipelineExcelsior SciencesDiscovery